News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
261,412 Results
Type
Article (13592)
Company Profile (110)
Press Release (247710)
Section
Business (87968)
Career Advice (463)
Deals (15327)
Drug Delivery (64)
Drug Development (36532)
Employer Resources (49)
FDA (6265)
Job Trends (6188)
News (150061)
Policy (14009)
Tag
Academia (436)
Alliances (23107)
Alzheimer's disease (353)
Approvals (6262)
Artificial intelligence (61)
Bankruptcy (143)
Best Places to Work (4334)
Biotechnology (44)
Breast cancer (45)
Cancer (324)
Career advice (406)
Cell therapy (44)
Clinical research (30419)
Collaboration (156)
Compensation (63)
COVID-19 (749)
C-suite (52)
Data (355)
Diabetes (53)
Diagnostics (1242)
Drug pricing (57)
Earnings (31568)
Employer resources (43)
Events (36774)
Executive appointments (174)
FDA (6449)
Funding (110)
Gene therapy (59)
GLP-1 (294)
Government (1268)
Healthcare (3526)
Infectious disease (767)
Inflammatory bowel disease (46)
Interviews (59)
IPO (5818)
Job creations (2050)
Job search strategy (372)
Layoffs (167)
Legal (3411)
Lung cancer (46)
Manufacturing (99)
Medical device (1264)
Medtech (1266)
Mergers & acquisitions (9546)
Metabolic disorders (168)
Neuroscience (452)
NextGen Class of 2024 (1580)
Non-profit (590)
Northern California (441)
Obesity (101)
Opinion (109)
Patents (54)
People (28471)
Pharmaceutical (64)
Phase I (7909)
Phase II (12861)
Phase III (11561)
Pipeline (185)
Policy (45)
Postmarket research (1399)
Preclinical (3166)
Radiopharmaceuticals (116)
Rare diseases (90)
Real estate (2630)
Regulatory (9827)
Research institute (563)
Resumes & cover letters (55)
Southern California (437)
Startups (1626)
United States (4343)
Vaccines (112)
Weight loss (78)
Date
Today (39)
Last 7 days (194)
Last 30 days (1194)
Last 365 days (12775)
2024 (11707)
2023 (14249)
2022 (19559)
2021 (20074)
2020 (19042)
2019 (14894)
2018 (11722)
2017 (13891)
2016 (13131)
2015 (15473)
2014 (12421)
2013 (10596)
2012 (11396)
2011 (11922)
2010 (10888)
Location
Africa (312)
Arizona (43)
Asia (19801)
Australia (2560)
California (1022)
Canada (611)
China (114)
Colorado (44)
Connecticut (42)
Europe (38799)
Florida (154)
Illinois (113)
Indiana (86)
Japan (43)
Kansas (51)
Maryland (158)
Massachusetts (890)
Minnesota (58)
New Jersey (430)
New York (283)
North Carolina (279)
Northern California (441)
Pennsylvania (289)
South America (498)
Southern California (437)
Texas (146)
Virginia (41)
Washington State (71)
261,412 Results for "verity pharmaceuticals".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Business
Lipocine Announces Continued Commercialization of TLANDO® through Verity Pharmaceuticals
Lipocine Inc. today announced that commercialization of TLANDO® in the U.S. has been transitioned to its licensee Verity Pharma, effective February 1, 2024 , enabling the continuity of patient access to TLANDO.
February 2, 2024
·
17 min read
Business
Lipocine and Verity Pharma Enter into License Agreement for TLANDO® Franchise in the U.S. and Canada
Lipocine Inc. (NASDAQ: LPCN), a biopharmaceutical company focused on treating Central Nervous System (CNS) disorders, Gordon Silver Limited and Verity Pharmaceuticals, Inc. (Verity Pharma) today announced that they have entered into an exclusive licensing agreement under which Verity Pharma will market TLANDO® in the United States and, if approved, in Canada.
January 18, 2024
·
19 min read
Business
Cumberland Pharmaceuticals Announces Key Co-Promotion Agreement with Verity Pharmaceuticals to Expand Support for Sancuso®
Specialty pharmaceutical company Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX) announced today that it has entered into a national co-promotion agreement with Verity Pharmaceuticals International Ltd. to support Cumberland’s new Sancuso® oncology support product.
May 9, 2022
·
5 min read
Acerus Pharmaceuticals Announces Commercial Agreement With Verity Pharmaceuticals for the Promotion of NATESTO® in Puerto Rico
Acerus Pharmaceuticals Corporation (the “Company” or “Acerus”) (TSX:ASP; OTCQB:ASPCF) today announced the signing of an agreement with Verity Pharmaceuticals (“Verity Pharma”) for the exclusive rights to promote NATESTO in Puerto Rico.
January 10, 2022
·
3 min read
Business
Verity Pharmaceuticals™ and Helsinn Therapeutics sign exclusive agreement for the promotion of Akynzeo® and Valchlor® in Puerto Rico
Verity Pharmaceuticals ™ and Helsinn Therapeutics sign exclusive agreement for the promotion of Akynzeo® and Valchlor® in Puerto Rico.
February 16, 2022
·
9 min read
Layoffs
Marinus Pharmaceuticals Lays Off 45% of Employees
The November layoffs are the second known workforce reduction this year for Marinus Pharmaceuticals, which previously announced disappointing Phase III results for ganaxolone in two clinical trials.
November 14, 2024
·
1 min read
·
Angela Gabriel
Business
Cipher Pharmaceuticals Enters into Co-Promotion Agreement with Verity Pharmaceuticals Inc.
Cipher Pharmaceuticals Inc. (TSX: CPH)today announced it has entered into an exclusive co-promotion agreement with Verity Pharmaceuticals Inc. for the marketing, sales and co-promotion of Brinavess, Aggrastat and Trevyent.
February 10, 2021
·
7 min read
Business
Debiopharm partners with Verity Pharmaceuticals for the exclusive US commercialization of Trelstar® for Prostate Cancer
Debiopharm and Verity Pharmaceuticals Inc. announced having entered into an exclusive agreement that grants Verity Pharmaceuticals Inc., in the United States of America, the rights to commercialize Trelstar® a hormone therapy for patients living with prostate cancer.
June 9, 2020
·
5 min read
Deals
Healthcare Solutions Holdings Announces Completion of Reverse Merger With Shareholders of Verity Corp.
Healthcare Solutions Management Group, Inc., a Delaware corporation and successor in interest to Verity Delaware Inc., a Delaware corporation, entered into a Merger Agreement by and between the Company, Verity Merger Corp., and Healthcare Solutions Holdings, Inc.
April 21, 2021
·
2 min read
Press Releases
Inflammatix Initiates TriVerity™ for Improved Management of Emergency Department Patients with Suspected Infections (TIMED) Trial
November 11, 2024
·
5 min read
1 of 26,142
Next